Prognostic model for esophagogastric variceal rebleeding after endoscopic treatment in liver cirrhosis: A Chinese multicenter study

Figure 3 Area under receiver operating curve for variceal rebleeding in the derivation cohort and external cohort with 6 weeks, 1 year, and 2 years. A: Area under receiver operating curve for variceal rebleeding in the derivation cohort with 6 weeks; B: Area under receiver operating curve for variceal rebleeding in the derivation cohort with 1 year; C: Area under receiver operating curve for variceal rebleeding in the derivation cohort with 2 years; D: Area under receiver operating curve for variceal rebleeding in external cohort with 6 weeks; E: Area under receiver operating curve for variceal rebleeding in external cohort with 1 year; F: Area under receiver operating curve for variceal rebleeding in external cohort with 2 years. AUC: Area under the receiver operating curve; REPET: Rebleeding event prediction following endoscopic treatment; CTP: Child-Turcotte-Pugh; MELD: Model for end-stage liver disease; FIB-4: Fibrosis 4; ALBI: Albumin-bilirubin.